$OP
OceanPal Inc.

2022 Q4 Form 20-F Financial Statement

#000110465923039283 Filed on March 30, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2022 Q2
Revenue $5.724M $5.115M $4.566M
YoY Change 329.09% -24.72%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.380M $946.0K $867.0K
YoY Change 219.44% -7.57%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.896M $1.171M $1.018M
YoY Change -684.32% -14.59%
% of Gross Profit
Operating Expenses $8.212M $4.015M $3.918M
YoY Change 584.33% -30.43%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$2.488M $1.100M $648.0K
YoY Change -1956.72% 49.49%
Income Tax
% Of Pretax Income
Net Earnings -$2.890M $1.100M $648.0K
YoY Change -2256.72% 49.49%
Net Earnings / Revenue -50.49% 21.51% 14.19%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.67 $36.88K $21.72K
COMMON SHARES
Basic Shares Outstanding 10.18M
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022 Q3 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.454M $10.26M $10.99M
YoY Change 405.32% 566343.3%
Cash & Equivalents $8.454M $10.26M $10.99M
Short-Term Investments
Other Short-Term Assets $1.126M $5.308M $7.244M
YoY Change 144.78% 973.65%
Inventory $334.0K $1.796M
Prepaid Expenses
Receivables $4.252M $495.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $14.17M $15.57M $18.23M
YoY Change 342.84% 712.1%
LONG-TERM ASSETS
Property, Plant & Equipment $63.67M $65.19M $44.08M
YoY Change 39.24% 41.26%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00
YoY Change
Other Assets $1.175M $1.051M $810.0K
YoY Change 673.03% 38.69%
Total Long-Term Assets $64.85M $66.24M $44.89M
YoY Change 41.34% 41.21%
TOTAL ASSETS
Total Short-Term Assets $14.17M $15.57M $18.23M
Total Long-Term Assets $64.85M $66.24M $44.89M
Total Assets $79.02M $81.81M $63.13M
YoY Change 61.0% 85.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $281.0K $327.0K
YoY Change 6.84% 16.53%
Accrued Expenses $1.154M $1.186M
YoY Change 202.89% 6.74%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.459M $2.786M $2.207M
YoY Change 164.12% 33.72%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.459M $2.786M $2.207M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $2.459M $2.786M $2.207M
YoY Change 164.12% 33.72%
SHAREHOLDERS EQUITY
Retained Earnings -$2.321M
YoY Change -3670.77%
Common Stock $102.0K
YoY Change 1033.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $76.56M $79.03M $60.92M
YoY Change
Total Liabilities & Shareholders Equity $79.02M $81.81M $63.13M
YoY Change 61.0% 85.46%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2022 Q2
OPERATING ACTIVITIES
Net Income -$2.890M $1.100M $648.0K
YoY Change -2256.72% 49.49%
Depreciation, Depletion And Amortization $4.896M $1.171M $1.018M
YoY Change -684.32% -14.59%
Cash From Operating Activities -$1.310M $449.0K $2.374M
YoY Change -50.12% -28.95%
INVESTING ACTIVITIES
Capital Expenditures $5.094M -$4.778M
YoY Change -40786.9% 16107.6%
Acquisitions
YoY Change
Other Investing Activities -$4.998M -$4.778M
YoY Change
Cash From Investing Activities -$96.00K -$220.0K -$4.778M
YoY Change 666.77% 16107.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -404.0K -954.0K 11.72M
YoY Change -109.29% -449.91%
NET CHANGE
Cash From Operating Activities -1.310M 449.0K 2.374M
Cash From Investing Activities -96.00K -220.0K -4.778M
Cash From Financing Activities -404.0K -954.0K 11.72M
Net Change In Cash -1.810M -725.0K 9.316M
YoY Change -205.8% -24810.88%
FREE CASH FLOW
Cash From Operating Activities -$1.310M $449.0K $2.374M
Capital Expenditures $5.094M -$4.778M
Free Cash Flow -$6.404M $7.152M
YoY Change 145.01% 112.18%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Auditor Name
AuditorName
Ernst and Young (Hellas), Certified Auditors Accountants S.A.
CY2022 dei Auditor Firm
AuditorFirmId
1457
CY2022 dei Auditor Location
AuditorLocation
Athens, Greece
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8454000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1673000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4252000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
811000
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001869467
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
882024
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
882024
CY2022 dei Entity Registrant Name
EntityRegistrantName
OceanPal Inc.
CY2022 op Historical Blended Average Year For Calculating Undiscounted Projected Net Operating Cash Flows
HistoricalBlendedAverageYearForCalculatingUndiscountedProjectedNetOperatingCashFlows
P10Y
CY2022 op Term For Time Charter Rates
TermForTimeCharterRates
P6M
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10183996
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
510000
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
519172
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
882024
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10183996
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
0
op Historical Blended Average Year For Calculating Undiscounted Projected Net Operating Cash Flows
HistoricalBlendedAverageYearForCalculatingUndiscountedProjectedNetOperatingCashFlows
P10Y
op Term For Time Charter Rates
TermForTimeCharterRates
P6M
op Historical Blended Average Year For Calculating Undiscounted Projected Net Operating Cash Flows
HistoricalBlendedAverageYearForCalculatingUndiscountedProjectedNetOperatingCashFlows
P10Y
CY2022 dei Document Type
DocumentType
20-F
CY2022 dei Document Registration Statement
DocumentRegistrationStatement
false
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Document Shell Company Report
DocumentShellCompanyReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-40930
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
1T
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
Pendelis 26
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
175 64
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Palaio Faliro
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Athens
CY2022 dei Entity Address Country
EntityAddressCountry
GR
CY2022 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value including the Preferred Stock Purchase Rights
CY2022 dei Trading Symbol
TradingSymbol
OP
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10183996
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Document Accounting Standard
DocumentAccountingStandard
U.S. GAAP
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
5000
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
70000
CY2022Q4 us-gaap Inventory Net
InventoryNet
334000
CY2021Q4 us-gaap Inventory Net
InventoryNet
186000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1126000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
460000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
14171000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
3200000
CY2022Q4 op Vessels Net
VesselsNet
63672000
CY2021Q4 op Vessels Net
VesselsNet
45728000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
63672000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
45728000
CY2022Q4 us-gaap Deferred Costs
DeferredCosts
1175000
CY2021Q4 us-gaap Deferred Costs
DeferredCosts
152000
CY2022Q4 us-gaap Assets
Assets
79018000
CY2021Q4 us-gaap Assets
Assets
49080000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
281000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
263000
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
410000
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
59000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1154000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
381000
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
374000
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
228000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2459000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
931000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
519172
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
510000
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
5000
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
5000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10183996
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
882024
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
102000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
9000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
78773000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
48070000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2321000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
65000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
76559000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
48149000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
79018000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
49080000
CY2022 us-gaap Revenues
Revenues
19085000
us-gaap Revenues
Revenues
1334000
CY2022 us-gaap Direct Operating Costs
DirectOperatingCosts
3680000
us-gaap Direct Operating Costs
DirectOperatingCosts
54000
CY2022 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
6880000
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
360000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4896000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
354000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3083000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
358000
CY2022 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
878000
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
74000
CY2022 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
6000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-326000
us-gaap Operating Income Loss
OperatingIncomeLoss
134000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-326000
us-gaap Net Income Loss
NetIncomeLoss
134000
CY2022 op Deemed Dividend On Preferred Stock Upon Exchange Of Common Stock
DeemedDividendOnPreferredStockUponExchangeOfCommonStock
134000
CY2022 op Dividends On Series C Preferred Stock
DividendsOnSeriesCPreferredStock
950000
op Dividends On Series C Preferred Stock
DividendsOnSeriesCPreferredStock
69000
CY2022 op Dividends On Series D Preferred Stock
DividendsOnSeriesDPreferredStock
252000
CY2022 op Dividends On Class Warrants
DividendsOnClassWarrants
1012000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2674000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
65000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.86
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.86
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3113108
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
882024
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3113108
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1227569
us-gaap Net Income Loss
NetIncomeLoss
134000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
40509000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
48149000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-326000
CY2022 op Stock Issued During Period Value Stock Issued In Primary Offering
StockIssuedDuringPeriodValueStockIssuedInPrimaryOffering
10695000
CY2022 op Stock Issued During Period Value On Warrants And Underwriters Over Allotment Option
StockIssuedDuringPeriodValueOnWarrantsAndUnderwritersOverAllotmentOption
898000
CY2022 op Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
3143000
CY2022 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
568000
CY2022 op Dividends Declared And Or Paid On Common Stock And Warrants First Occasion During Period
DividendsDeclaredAndOrPaidOnCommonStockAndWarrantsFirstOccasionDuringPeriod
2215000
CY2022 op Dividends Declared And Or Paid On Common Stock And Warrants Second Occasion During Period
DividendsDeclaredAndOrPaidOnCommonStockAndWarrantsSecondOccasionDuringPeriod
886000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
76559000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-326000
us-gaap Net Income Loss
NetIncomeLoss
134000
CY2022 us-gaap Depreciation
Depreciation
4896000
us-gaap Depreciation
Depreciation
354000
CY2022 us-gaap Restricted Stock Expense
RestrictedStockExpense
568000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3441000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-24000
CY2022 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-65000
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
70000
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
148000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-23000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
666000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
460000
CY2022 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-152000
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
152000
CY2022 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
18000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
263000
CY2022 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
351000
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
59000
CY2022 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
842000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
312000
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
146000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
228000
CY2022 op Payment On Drydock Costs Operating Activities
PaymentOnDrydockCostsOperatingActivities
944000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1513000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
715000
CY2022 op Payments For Vessel Improvements And Vessel Acquisitions
PaymentsForVesselImprovementsAndVesselAcquisitions
5094000
op Payments For Vessel Improvements And Vessel Acquisitions
PaymentsForVesselImprovementsAndVesselAcquisitions
42000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5094000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-42000
op Proceeds From Spin Off
ProceedsFromSpinOff
1000000
CY2022 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
16195000
CY2022 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1835000
CY2022 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3101000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10362000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1000000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6781000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1673000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1673000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8454000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1673000
us-gaap Stock Issued1
StockIssued1
47084000
CY2022 op Dividends On Preferred Stock Declared Not Paid
DividendsOnPreferredStockDeclaredNotPaid
240000
CY2022 op Deemed Dividend On Series D Preferred Stock Upon Redemption And Issuance Of Common Stock
DeemedDividendOnSeriesDPreferredStockUponRedemptionAndIssuanceOfCommonStock
-134000
CY2022 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
17600000
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
op Number Of Subsidiaries Acquired Through Spin Off Transaction
NumberOfSubsidiariesAcquiredThroughSpinOffTransaction
3
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">b) Use of Estimates: </span>The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
15000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
op Term For Time Charter Rates
TermForTimeCharterRates
P6M
CY2022 op Historical Blended Average Year For Calculating Undiscounted Projected Net Operating Cash Flows
HistoricalBlendedAverageYearForCalculatingUndiscountedProjectedNetOperatingCashFlows
P10Y
CY2022 op Term For Time Charter Rates
TermForTimeCharterRates
P6M
CY2021Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2021Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2022 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P25Y
us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P25Y
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">l) Concentration of Credit Risk</span>: Financial instruments, which potentially subject the Company to significant concentrations of credit risk, consist principally of cash, trade accounts receivable and amounts due to/from related parties. The Company places its temporary cash investments, consisting mostly of deposits, with various qualified financial institutions and performs periodic evaluations of the relative credit standing of those financial institutions that are considered in the Company’s investment strategy. The Company limits its credit risk with accounts receivable by performing ongoing credit evaluations of its customers’ financial condition and generally does not require collateral for its accounts receivable and does not have any agreements to mitigate credit risk (Note 9).</p>
CY2022 op Gain Loss On Bunkers
GainLossOnBunkers
-1949000
op Gain Loss On Bunkers
GainLossOnBunkers
63000
CY2022 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2022 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
0
CY2022 op Exchange Shares Of Convertible Preferred Stock For Shares Of Common Stock
ExchangeSharesOfConvertiblePreferredStockForSharesOfCommonStock
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">w) Redemption of Shares of Convertible Preferred Stock for issuance of Shares of Common Stock:</span> In case of conversion of preferred stock to common stock, with the conversion feature assessed by the Company at first as per ASC 480-10-25-14 and then determined as requiring evaluation as a redemption feature (Note 2(v)), the Company considers  as applicable the redemption accounting. A redemption of preferred stock according to its original terms may be paid using cash, other instruments issued by the issuer or other assets (individually and collectively, the consideration) and may include a premium or discount. As per ASC 260-10-S99-2 a premium paid on redemption represents a return similar to a dividend to the preferred holder. In particular, when the Company determines that on the redemption date there is a difference in the carrying value of the preferred stock, as compared to the fair value of the common shares issued, that value represents a dividend to the preferred holders, which should be deducted from (if a premium) or added to (if a discount) the net income/(loss) to arrive at the net income/(loss) available to common stockholders (Note 6(h) and 7).</p>
CY2022 op Deferred Offering Expenses
DeferredOfferingExpenses
376000
op Deferred Offering Expenses
DeferredOfferingExpenses
152000
CY2022 us-gaap Malpractice Insurance Maximum Coverage Per Incident
MalpracticeInsuranceMaximumCoveragePerIncident
1000000000
CY2022 op Term For Adjustment Of Estimates
TermForAdjustmentOfEstimates
P3Y
CY2022Q4 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
1597000
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
882024
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10183996
CY2022Q1 op Minimum Bid Price Requirement For Continued Listing On Nasdaq Per Share
MinimumBidPriceRequirementForContinuedListingOnNasdaqPerShare
1.00
CY2022Q1 op Grace Period To Regain Compliance With Nasdaq Bid Price Requirements
GracePeriodToRegainComplianceWithNasdaqBidPriceRequirements
P180D
CY2022Q3 op Grace Period To Regain Compliance With Nasdaq Bid Price Requirements
GracePeriodToRegainComplianceWithNasdaqBidPriceRequirements
P180D
CY2022Q3 op Minimum Bid Price Requirement For Continued Listing On Nasdaq Per Share
MinimumBidPriceRequirementForContinuedListingOnNasdaqPerShare
1.00
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
14736
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 op Percentage Of Discount Factor
PercentageOfDiscountFactor
0.127
CY2022Q4 op Percentage Of Risk Free Rate
PercentageOfRiskFreeRate
0.01
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.5
CY2022Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
2215000
CY2022Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.1
CY2022Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
443000
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.1
CY2022Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
443000
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-326000
us-gaap Net Income Loss
NetIncomeLoss
134000
CY2022 op Deemed Dividend On Preferred Stock Upon Exchange Of Common Stock
DeemedDividendOnPreferredStockUponExchangeOfCommonStock
134000
op Deemed Dividend On Preferred Stock Upon Exchange Of Common Stock
DeemedDividendOnPreferredStockUponExchangeOfCommonStock
0
CY2022 op Dividends On Series C Preferred Stock
DividendsOnSeriesCPreferredStock
950000
op Dividends On Series C Preferred Stock
DividendsOnSeriesCPreferredStock
69000
CY2022 op Dividends On Class Warrants
DividendsOnClassWarrants
1012000
op Dividends On Class Warrants
DividendsOnClassWarrants
0
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2674000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
65000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3113108
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
882024
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
345545000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3113108
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1227569
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.86
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.86
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2022Q4 op Maximum Exposure To Credit Risk On Charter Contracts With Significant Customers
MaximumExposureToCreditRiskOnCharterContractsWithSignificantCustomers
215000
CY2021Q4 op Maximum Exposure To Credit Risk On Charter Contracts With Significant Customers
MaximumExposureToCreditRiskOnCharterContractsWithSignificantCustomers
811000
us-gaap Net Income Loss
NetIncomeLoss
750983
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-3795959
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-1862852
us-gaap Depreciation
Depreciation
2192911
CY2020 us-gaap Depreciation
Depreciation
2151977
CY2019 us-gaap Depreciation
Depreciation
2479432
CY2019 us-gaap Asset Impairment Charges
AssetImpairmentCharges
3047978
CY2020 op Assets Fair Value Adjustments
AssetsFairValueAdjustments
200500
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-169243
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
725324
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
302696
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
14418
CY2020 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
1167746
CY2019 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
1891
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
26611
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
13199
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-392255
op Increase Decrease In Insurance Claims
IncreaseDecreaseInInsuranceClaims
-941488
CY2020 op Increase Decrease In Insurance Claims
IncreaseDecreaseInInsuranceClaims
-1145969
CY2019 op Increase Decrease In Insurance Claims
IncreaseDecreaseInInsuranceClaims
2078347
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-191097
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
155786
CY2019 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
403488
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
87213
CY2020 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-47062
CY2019 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-160921
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-115280
CY2020 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-122741
CY2019 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
220261
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-1125141
CY2020 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
1189260
CY2019 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
202046
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
135080
CY2020 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-155877
CY2019 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-90092
op Payment Of Drydock Costs Operating Activities
PaymentOfDrydockCostsOperatingActivities
5535
CY2020 op Payment Of Drydock Costs Operating Activities
PaymentOfDrydockCostsOperatingActivities
826180
CY2019 op Payment Of Drydock Costs Operating Activities
PaymentOfDrydockCostsOperatingActivities
2234
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3181030
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2723168
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1439451
op Payments For Vessel Improvements
PaymentsForVesselImprovements
23850
CY2020 op Payments For Vessel Improvements
PaymentsForVesselImprovements
1474965
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23850
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1474965
us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
-3196728
CY2020 us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
4235856
CY2019 us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
-1504222
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3196728
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4235856
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1504222
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-39548
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
37723
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-64771
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
39638
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1915
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66686
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
90
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
39638
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1915
CY2020 op Property Plant And Equipment Vessel Fair Value Adjustment
PropertyPlantAndEquipmentVesselFairValueAdjustment
200500
CY2020 op Property Plant And Equipment Vessel Transferred From Held For Sale
PropertyPlantAndEquipmentVesselTransferredFromHeldForSale
7129500
CY2020 op Property Plant And Equipment Vessel Transferred From Held For Sale Net
PropertyPlantAndEquipmentVesselTransferredFromHeldForSaleNet
7129500

Files In Submission

Name View Source Status
0001104659-23-039283-index-headers.html Edgar Link pending
0001104659-23-039283-index.html Edgar Link pending
0001104659-23-039283.txt Edgar Link pending
0001104659-23-039283-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
op-20221231.xsd Edgar Link pending
op-20221231x20f.htm Edgar Link pending
op-20221231xex12d1.htm Edgar Link pending
op-20221231xex12d2.htm Edgar Link pending
op-20221231xex13d1.htm Edgar Link pending
op-20221231xex13d2.htm Edgar Link pending
op-20221231xex2d13.htm Edgar Link pending
op-20221231xex2d6.htm Edgar Link pending
op-20221231xex2d6001.jpg Edgar Link pending
op-20221231xex2d6002.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
op-20221231x20f_htm.xml Edgar Link completed
op-20221231_cal.xml Edgar Link unprocessable
op-20221231xex2d9.htm Edgar Link pending
op-20221231xex4d11.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
op-20221231_def.xml Edgar Link unprocessable
op-20221231_lab.xml Edgar Link unprocessable
op-20221231_pre.xml Edgar Link unprocessable
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending